☆ 4.5 Article

Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center

JOURNAL OF SURGICAL ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Surgery

Sentinel Node Biopsy Alone or With Axillary Dissection in Breast Cancer Patients After Primary Chemotherapy: Long-Term Results of a Prospective Interventional Study

Gabriele Martelli et al.

Summary: The study confirms that in cN0/1 breast cancer patients who undergo primary chemotherapy followed by sentinel node biopsy, if the sentinel nodes are clear (pN0), performing only SNB can be an effective axillary treatment without impacting overall survival or disease-free survival.

ANNALS OF SURGERY (2022)

添加到收藏夹

Article Surgery

Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center

Rachel E. Sargent et al.

Summary: This study assessed prognostic factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer. The findings showed that pathologic complete response, node-negativity after neoadjuvant chemotherapy, and triple-negative subtype were associated with better relapse-free survival.

AMERICAN JOURNAL OF SURGERY (2022)

添加到收藏夹

Article Oncology

Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer

Stephanie M. Wong et al.

Summary: This study demonstrates that sentinel lymph node biopsy alone for patients who convert to pathologic node-negativity after neoadjuvant chemotherapy is associated with low short-term axillary recurrence rates. Additional follow-up data from prospective clinical trials are needed to confirm long-term oncologic safety and optimal local therapy recommendations.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

Sabrina Kahler-Ribeiro-Fontana et al.

Summary: This study evaluated the outcomes of patients undergoing NAT who remained or converted to cN0 and received SNB, showing a high overall survival rate after 10-year follow-up. The use of standard SNB in cN1/2 patients who become cN0 after NAT was deemed acceptable and did not result in worse outcomes.

EJSO (2021)

添加到收藏夹

Article Oncology

Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event

Andrea Barrio et al.

Summary: This study examined nodal recurrence rates in patients with clinically node-positive cancer treated with sentinel lymph node biopsy after neoadjuvant chemotherapy, showing low rates of axillary failure at a median follow-up of 40 months, supporting potential omission of axillary lymph node dissection in patients achieving nodal pathologic complete response with SLNB alone.

JAMA ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy

Hyunhee Kim et al.

Summary: The study found no significant difference in breast cancer recurrence and survival rates between patients who underwent SLNB and ALND after converting from lymph node-positive to ypN0 status. Patients in the ALND group were more likely to experience complications such as shoulder stiffness and lymphedema compared to the SLNB group.

JOURNAL OF BREAST CANCER (2021)

添加到收藏夹

Article Oncology

Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach

Andrea P. Damin et al.

Summary: In breast cancer patients who transition from cN1/2 to cN0 after neoadjuvant chemotherapy, sentinel lymph node biopsy (SLNB) may safely guide a more selective axillary approach. Omitting axillary lymph node dissection (ALND) in cN0 patients with negative SLNs does not appear to compromise disease control or oncological outcomes.

BREAST CANCER RESEARCH AND TREATMENT (2021)

添加到收藏夹

Article Oncology

Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer

Mara A. Piltin et al.

ANNALS OF SURGICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean-Marc Classe et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

添加到收藏夹

Article Medicine, General & Internal

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

Armando E. Giuliano et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

添加到收藏夹

Article Oncology

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

Abigail S. Caudle et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

Jean-Francois Boileau et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Surgery

Selective Surgical Localization of Axillary Lymph Nodes Containing Metastases in Patients With Breast Cancer A Prospective Feasibility Trial

Abigail S. Caudle et al.

JAMA SURGERY (2015)

添加到收藏夹

Article Medicine, General & Internal

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Patricia Cortazar et al.

LANCET (2014)

添加到收藏夹

Article Medicine, General & Internal

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial

Judy C. Boughey et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Article Oncology

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Thorsten Kuehn et al.

LANCET ONCOLOGY (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.